Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111518021B reveals a novel iodide-catalyzed oxidative cyclization using styrene and DMF, offering a cost-effective, metal-free route for high-purity pharmaceutical intermediates.
Novel Pd-catalyzed route for indolone thioesters using sulfonyl chloride. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN103351291B details high-purity Phloretin production. Offers cost reduction and supply chain reliability for cosmetic and pharma industries.
Patent CN112898192B reveals a novel Pd-catalyzed route to N-acyl indoles using solid CO surrogates, offering safer scalable manufacturing for pharmaceutical intermediates.
Patent CN104945231B details a catalyst-free 1,4-diketone synthesis. This method offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.
Patent CN106928142A reveals a metal-free synthesis for 1,3-isoquinolinedione derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111100085A reveals a green deep eutectic solvent method for synthesizing benzoxazine derivatives, offering cost reduction in API manufacturing and scalable production.
Patent CN102180843A reveals a novel route for 2-(2-amino-4-thiazolyl)-2(Z)-trityloxyiminoacetic acid. Achieve significant cost reduction and supply reliability in cephalosporin manufacturing.
Novel Pd-catalyzed defluoroalkynylation method for high-purity naphthofuran intermediates. Cost-effective route for pharmaceutical and material applications.
Patent CN112142680B details a metal-free photocatalytic route for 3-trifluoroalkylquinoxalinones, offering cost-effective and scalable manufacturing for pharmaceutical intermediates.
Patent CN113929569A reveals a mild, high-yield route for monofluoro iodoacetone compounds. Discover cost-effective manufacturing and scalable supply solutions for fluorinated intermediates.
Patent CN112920173A details a mild, high-yield synthesis of chiral chromans with potent anticancer activity, offering reliable supply chain solutions.
Novel Pd-catalyzed bis-carbonylation route offers high yields and broad substrate scope for bioactive scaffolds, ensuring reliable supply chain stability.
Novel elemental sulfur-promoted synthesis method significantly reduces costs and improves safety for high-purity pharmaceutical intermediate manufacturing supply chains globally without heavy metals.
Patent CN107936025B details metal-free synthesis offering high stereoselectivity and supply chain stability for pharmaceutical intermediate manufacturing.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity, scalable process for pharmaceutical intermediates. Reduces lead time for high-purity API intermediate manufacturing.
Patent CN113121462B reveals a metal-free route to 5-CF3 triazoles using diazo compounds. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN105152946B enables one-step synthesis of o-Aminobenzaldehyde. High purity, mild conditions, and scalable ionic liquid catalysis for pharmaceutical supply chains.
Novel visible light iron catalysis method for 4-arylbutyronitrile. Offers 100% atom economy and mild conditions for scalable pharmaceutical intermediate manufacturing.